Countering amyloid polymorphism and drug resistance with minimal drug cocktails.

Countering amyloid polymorphism and drug resistance with minimal drug cocktails.

Item
http://www.wikidata.org/entity/Q40749941
The chaperone-like protein 14-3-3η interacts with human α-synuclein aggregation intermediates rerouting the amyloidogenic pathway and reducing α-synuclein cellular toxicityThe Surprising Role of Amyloid Fibrils in HIV InfectionThe tip of the iceberg: RNA-binding proteins with prion-like domains in neurodegenerative disease.Prions on the move.Epigallocatechin-3-gallate rapidly remodels PAP85-120, SEM1(45-107), and SEM2(49-107) seminal amyloid fibrils.Hsp104 drives "protein-only" positive selection of Sup35 prion strains encoding strong [PSI(+)].Multiple discrete soluble aggregates influence polyglutamine toxicity in a Huntington's disease model systemThe role of amyloidogenic protein oligomerization in neurodegenerative disease.Harnessing the power of yeast to unravel the molecular basis of neurodegeneration.Biology and Pathobiology of TDP-43 and Emergent Therapeutic Strategies.
P2860

Countering amyloid polymorphism and drug resistance with minimal drug cocktails.

Item
http://www.wikidata.org/entity/Q40749941
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Countering amyloid polymorphism and drug resistance with minimal drug cocktails.
@en
type
label
Countering amyloid polymorphism and drug resistance with minimal drug cocktails.
@en
prefLabel
Countering amyloid polymorphism and drug resistance with minimal drug cocktails.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P932
P356
P1433
P1476
Countering amyloid polymorphism and drug resistance with minimal drug cocktails.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P5875
P698
P932